Rates of malignancy associated with juvenile idiopathic arthritis and its treatment-Reference-Cited by-同舟云学术

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

Published:2012-03-27 Issue:4 Volume:64 Page:1263-1271
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Beukelman Timothy,Haynes Kevin,Curtis Jeffrey R.,Xie Fenglong,Chen Lang,Bemrich-Stolz Christina J.,Delzell Elizabeth,Saag Kenneth G.,Solomon Daniel H.,Lewis James D.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference35 articles.

1. Etanercept in children with polyarticular juvenile rheumatoid arthritis;Lovell;N Engl J Med,2000

2. The German etanercept registry for treatment of juvenile idiopathic arthritis;Horneff;Ann Rheum Dis,2004

3. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis;Henrickson;J Rheumatol,2004

4. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis;Lovell;N Engl J Med,2008

5. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis;Lovell;Arthritis Rheum,2008

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Safe Are Biological Agents in Pediatric Rheumatology?;Turkish Archives of Pediatrics;2024-03-01

2. Juvenile Idiopathic Arthritis;Care of Adults with Chronic Childhood Conditions;2024

3. Dual direction associations between common autoimmune diseases and leukemia among children and young adults: A systematic review;Cancer Epidemiology;2023-10

4. Associative gene networks reveal novel candidates important for ADHD and dyslexia comorbidity;BMC Medical Genomics;2023-09-04

5. Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis;Rheumatology;2023-05-04